In the last 12 months, insiders at eFFECTOR Therapeutics, Inc. ($EFTR) filed 17 transactions with the SEC: 0 open-market purchases totaling $0 and 0 sales totaling $0. Net insider sentiment: neutral.
eFFECTOR Therapeutics, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- WORLAND STEPHEN T (Chief Executive Officer) — 2 transactions totaling $3,040
- Byrnes Michael (Chief Financial Officer) — 2 transactions totaling $2,334
- Klencke Barbara (Director) — 1 transaction totaling $0
- Loewy Caroline M (Director) — 1 transaction totaling $0
- Warner Douglas J (Chief Medical Officer) — 1 transaction totaling $0
View all SEC Filings for eFFECTOR Therapeutics, Inc. (EFTR).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| June 13, 2024 | Loewy Caroline M | Not found | A | Stock Option (Right to Buy) | 800 | $0.00 | 800.0000 | 4,704,409 | 9999.99% | 0.02% |
| June 13, 2024 | Klencke Barbara | Not found | A | Stock Option (Right to Buy) | 800 | $0.00 | 800.0000 | 4,704,409 | 9999.99% | 0.02% |
| June 13, 2024 | Ehrlich Christopher B | Not found | A | Stock Option (Right to Buy) | 800 | $0.00 | 800.0000 | 4,704,409 | 9999.99% | 0.02% |
| June 13, 2024 | Harrington-Smith Kristen | Not found | A | Stock Option (Right to Buy) | 800 | $0.00 | 800.0000 | 4,704,409 | 9999.99% | 0.02% |
| June 13, 2024 | Gallagher Brian M. Jr. | Not found | A | Stock Option (Right to Buy) | 800 | $0.00 | 800.0000 | 4,704,409 | 9999.99% | 0.02% |
| June 13, 2024 | Bhatt Elizabeth | Not found | A | Stock Option (Right to Buy) | 800 | $0.00 | 800.0000 | 4,704,409 | 9999.99% | 0.02% |
| May 15, 2024 | Byrnes Michael | Chief Financial Officer | A | Common Stock | 1387 | $1.68 | 3,117.0000 | 4,704,409 | 80.17% | 0.03% |
| May 15, 2024 | WORLAND STEPHEN T | Chief Executive Officer | A | Common Stock | 1806 | $1.68 | 34,987.0000 | 4,704,409 | 5.44% | 0.04% |
| Feb. 19, 2024 | Loewy Caroline M | Director | A | Stock Option (Right to Buy) | 2000 | $0.00 | 2,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 19, 2024 | Bhatt Elizabeth | Director | A | Stock Option (Right to Buy) | 2000 | $0.00 | 2,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 19, 2024 | Ehrlich Christopher B | Director | A | Stock Option (Right to Buy) | 2000 | $0.00 | 2,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 19, 2024 | Klencke Barbara | Director | A | Stock Option (Right to Buy) | 2000 | $0.00 | 2,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 19, 2024 | Harrington-Smith Kristen | Director | A | Stock Option (Right to Buy) | 2000 | $0.00 | 2,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 19, 2024 | Gallagher Brian M. Jr. | Director | A | Stock Option (Right to Buy) | 2000 | $0.00 | 2,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 19, 2024 | Byrnes Michael | Chief Financial Officer | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 19, 2024 | Warner Douglas J | Chief Medical Officer | A | Stock Option (Right to Buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 19, 2024 | WORLAND STEPHEN T | Chief Executive Officer | A | Stock Option (Right to Buy) | 80000 | $0.00 | 80,000.0000 | 0 | 9999.99% | 0.00% |